Core Insights - Eli Lilly and Company (NYSE: LLY) is forming a strategic collaboration with Repertoire Immune Medicines, potentially worth up to $1.93 billion, aimed at developing new treatments for multiple autoimmune diseases [2][3]. Group 1: Collaboration Details - Under the agreement, Repertoire will receive an upfront payment of $85 million, with an additional $1.84 billion contingent on development and commercial milestones [3]. - The collaboration includes tiered royalties on future net sales, focusing on therapies that restore the immune system without broad immune suppression [3]. Group 2: Access to Technology - As part of the collaboration, Eli Lilly will gain access to Repertoire's Decode platform, which studies T cell recognition and binding to specific targets on diseased cells [4]. - Repertoire will handle early discovery work, after which Eli Lilly will take over clinical development, manufacturing, regulatory activities, and commercialization [4]. Group 3: Strategic Expansion - Eli Lilly is actively expanding its immunology business through various deals and acquisitions, including the $3.2 billion acquisition of Morphic Holding in 2024 to enhance its inflammatory bowel disease pipeline [5]. - The current immunology portfolio of Eli Lilly includes treatments such as Olumiant, Taltz, and Omvoh, addressing conditions like arthritis, immune-related hair loss, psoriasis, and chronic bowel disorders [6].

Core Viewpoint - Diamondback Energy, Inc. (NASDAQ:FANG) is recognized as a promising investment opportunity, particularly noted for its inclusion among the best low-risk dividend stocks [1]. Group 1: Price Target and Analyst Ratings - Piper Sandler has raised its price target for Diamondback Energy to $218 from $215, maintaining an 'Overweight' rating [3]. - The firm anticipates that gas-focused companies will report strong Q4 results, while oil producers face challenges due to WAHA pricing and declining oil and NGL prices [3]. Group 2: Operational Performance - In Q4, Diamondback Energy experienced a decline in oil prices, with the average realized oil price falling to $58.00 per barrel from $64.60 in Q3, reflecting a 9.2% decrease in crude prices [4]. - The market's focus on oversupply and tariff concerns overshadowed geopolitical risks during this period [4]. Group 3: Earnings Expectations - Analysts project that Diamondback will report adjusted earnings of $2.64 per share for Q4 and $12.98 per share for the full year, based on estimates from LSEG [5].

Core Insights - Crystal International is advancing its strategy to integrate cutting-edge technology across its operations, focusing on digitalization and automation to enhance efficiency and sustainability [1][4]. Group 1: New Facility and Technology Integration - A new facility is being constructed by the company's knits division in its lifestyle wear factory in China, featuring an automated cutting workshop and a centralized smart warehouse with an advanced storage and retrieval system (AS/RS) [2]. - The logistics center, powered by a rooftop solar photovoltaic (PV) system, is expected to commence full operations in the first quarter of 2026, aiming to reduce fabric transfer times by up to 75% [3]. - The AS/RS will facilitate the autonomous flow of fabric materials and finished goods, while Automated Guided Vehicles (AGVs) will enhance the movement of sewn parts, contributing to a fully closed-looped auto-material flow system [3]. Group 2: Strategic Goals and Sustainability - The initiative aligns with Crystal International's Crystal Sustainability Vision 2030, which aims to transform all facilities into smart factories through innovative technology, thereby improving operational efficiency and sustainability performance [4]. - In October 2025, Crystal International became a partner member of Textile Exchange, a global non-profit organization promoting sustainability in the fashion and textile industries, which will help the company increase its use of eco-friendly options [6]. Group 3: Company Overview - Founded in 1970, Crystal International operates over 20 production sites across five countries, including Vietnam, China, Cambodia, Bangladesh, and Sri Lanka, producing a diverse range of apparel products [5]. - The company employs a "Co-creation" business model, collaborating with leading global brands to deliver high-quality and innovative manufacturing solutions [5].

Trump's Fed Pick Is Spooking Markets. Why Stocks, Bitcoin, Gold Are Reacting to Warsh and 5 More Things to Know Today. - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# Trump's Fed Pick Is Spooking Markets. Why Stocks, Bitcoin, Gold Are React ...

This week's jobs report could come with a shock, lawmakers contend with another government shutdown, Bitcoin hits 10-month low, and more news to start your day. ...

received $3.62 billion worth of inflows, the highest since at least 2009. Cumulatively, these ETFs received a record $91.86 billion worth of inflows in 2025, more than eight times the total in 2024. However, gold prices have fallen roughly 10% in the past two days after hitting record highs last week, as CME Group raised margin requirements following a sharp metals selloff that was triggered by Kevin Warsh's nomination as the next U.S. Federal Reserve Chair. Live Events Analysts at J.P. Morgan expect the ra ...

Core Insights - Arctic Vision has signed an agreement to acquire the ophthalmic device business of MDCO Technology, integrating MDCO's intraocular lens, implantable contact lens, and refractive device platforms into its global innovation framework for ophthalmic solutions [1][2]. Group 1: Acquisition Details - The acquisition aims to enhance Arctic Vision's capabilities by combining MDCO's advanced device engineering and manufacturing with its existing R&D in therapies, aligning with its strategy to expand its pipeline in areas with significant unmet needs in the ophthalmic sector [2][3]. - Following the acquisition, MDCO will operate as a wholly owned subsidiary of Arctic Vision, allowing for a more integrated approach to product development and market reach [3]. Group 2: Operational Structure - The combined group will maintain operations in three locations: Shanghai for biopharmaceutical research and regulatory affairs, Hangzhou for device R&D, manufacturing, and commercial management, and California for design and global collaboration [4]. - MDCO specializes in cataract and myopia-correction solutions, leveraging nearly two decades of expertise in materials science and precision moulding, with its Hangzhou site serving as the center for operations [4]. Group 3: Strategic Vision - Arctic Vision's founder, Dr. Eddy Wu, stated that this transaction represents a pivotal step for the company's long-term growth strategy, establishing a comprehensive ophthalmic innovation ecosystem that integrates scientific excellence with advanced manufacturing and commercial scale [5]. - The company is positioning itself for broader global investment participation and future capital-market opportunities, aiming to expand its ability to reach more patients and deliver greater impact across the ophthalmology community worldwide [6].

Group 1 - Brown & Brown, Inc. (NYSE:BRO) is recognized as one of the 7 Best Low-Risk Dividend Stocks to Invest in [1] - The company operates as an insurance broker, focusing on risk management across property, casualty, and employee benefits insurance products [2] - BMO Capital reduced its price target for Brown & Brown from $88 to $81 while maintaining a 'Market Perform' rating, noting the stock appears discounted compared to its historical P/E ratio with the S&P 500 [3] Group 2 - Brown & Brown reported a higher adjusted profit for Q4, driven by a 36% year-over-year increase in commissions and fees, totaling $1.58 billion [4][5] - Total revenue for the quarter reached $1.61 billion, up from $1.18 billion in the same quarter last year, while organic revenue decreased to $1.08 billion from $1.11 billion year-over-year [4][5] - Adjusted earnings per share increased to $0.93, up from $0.86 in the prior-year period [5]

Company Overview - HF Sinclair Corporation (NYSE:DINO) is a U.S.-based petroleum refiner focusing on products such as gasoline, diesel, jet fuel, and related offerings [2]. Analyst Insights - Morgan Stanley analyst Joe Laetsch raised the price target for HF Sinclair Corporation to $61 from $60, maintaining an Overweight rating, noting that refining stocks have increased about 10% year-to-date due to wider light and heavy crude differentials linked to recent events in Venezuela [3]. - The firm's Q1 EPS estimates for large-cap refiners are approximately 5% to 10% below consensus on average, as part of Morgan Stanley's Q4 preview for the sector, while maintaining a positive long-term outlook on refining despite rating the industry In-Line due to valuations [4]. Acquisition Details - On December 8, HF Sinclair Corporation announced that one of its subsidiaries signed a definitive agreement to acquire Industrial Oils Unlimited for $38 million, which includes around $15 million of working capital, implying an EBITDA multiple of about 3.5x once synergies are included based on expectations for 2027 [5]. - The acquisition of IOU, known for its value-added service model and customized solutions, is expected to enhance HF Sinclair's position in lubricants and specialty fluids, with management viewing the transaction as a step toward expanding its role as an innovator in that market [6].

Dmitry Vinogradov/iStock Editorial via Getty Images Listen below or on the go via Apple Podcasts and Spotify Stock index futures signal another red day for Wall Street. (00:14) Oil prices drop over 5% as Iran de-escalation talks weigh on market. (01:26) Crypto slide intensifies as Bitcoin hits around $75,000. (02:25) This is an abridged transcript. Wall Street could be looking at another red day with futures falling. Nasdaq 100 futures (US100:IND) are down 0.8%. S&P 500 futures (SPX) declined 0.5%, a ...